🇺🇸 FDA
Patent

US 7939635

Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy

granted A61KA61K38/00

Quick answer

US patent 7939635 (Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy) held by The United States of America, as represented by the Department of Health and Human Services expires Mon May 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue May 10 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 05 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K38/00